CAMBRIDGE, Mass., Nov. 11 /PRNewswire-FirstCall/ -- ViaCell, Inc. today announced that the Company will present at the 2005 Credit Suisse First Boston Healthcare Conference taking place November 15-18, 2005 at the Arizona Biltmore in Phoenix, Arizona. Marc D. Beer, President and Chief Executive Officer, will present an overview of ViaCell’s business activities and product pipeline at 3:00 p.m. MST on Wednesday, November 16, 2005. A live audio webcast of this presentation will be available within the Investor Information section of the ViaCell website at http://www.viacellinc.com. A replay will be available for approximately 30 days after the webcast.
ViaCell is a biotechnology company focused on enabling the widespread use of human cells as medicine. The Company is developing a pipeline of proprietary stem cell product candidates intended to address cancer, cardiac disease, and diabetes. CB001, its lead cord blood derived stem cell therapy product candidate, is being developed for hematopoietic stem cell transplantation in patients affected by a variety of cancers. In addition to its therapeutic development programs, ViaCell’s reproductive health business unit commercializes ViaCord(R), a product that offers expecting families the option of preserving their baby’s umbilical cord blood. The Company is working to leverage its commercial infrastructure and product development capabilities by developing ViaCyte(TM), its investigational product intended to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs. ViaCell is headquartered in Cambridge, Massachusetts with a processing and storage facility in Kentucky and additional research and development operations in Singapore.
ViaCell(R) and ViaCord(R) are registered trademarks and ViaCyte(TM) is a trademark of ViaCell, Inc.
For More Information Contact: Justine E. Koenigsberg Senior Director, Corporate Communications (617) 914-3494
ViaCell, Inc.
CONTACT: Justine E. Koenigsberg, Senior Director, CorporateCommunications, +1-617-914-3494
Web site: http://www.viacellinc.com//
